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Parturient paresis, milk fever, is a complex metabolic disorder that 
occurs near parturition in dairy cows. Parturient paresis has been in­
vestigated extensively since the 1950s- One research area of parturient 
paresis prevention that has received much attention during this time 
period has been the administration of vitamin D. Vitamin D has been fed 
to dairy cows either prepartum or continuously year around. Vitamin D 
and its metabolites and analogs also have been administered intramuscu­
larly in attempts to prevent parturient paresis. No reports are available 
in the literature describing the effects of ruminai microorganisms on 
dietary vitamin D, even though the oral administration of vitamin D to 
cows has been used extensively. 
It is known that vitamin A and phyto-estrogens are degraded in the 
rumen while steroids, such as cholesterol, are degraded in the intestinal 
tract. Evidence indicates that a dairy cow cannot tolerate much more than 
30 X 10^ ITJ of vitamin D3 intramuscularly, but readily can handle 20 x 10^ 
to 30 X 10^ lU of vitamin D2 per day orally for up to 10 days. Evidently, 
some undescribed event(s) take(s) place in the gastrointestinal tract of 
ruminants to prevent vitamin D toxicity after massive oral intakes of 
vitamin D. Thus, vitamin D seems to be degraded in the rumen. 
Therefore, the first phase of this study will deal with an in-depth 
investigation of the effects of rumen microorganisms on consumed vitamin 
D. The second phase will evaluate vitamin D2 and vitamin Dg metabolism 
in ruminants after the oral administration of these two vitamins. It is 
becoming evident that vitamin D2 and vitamin D3 are not metabolized in 
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the same fashion in ruminants. While dairy cows given 20 x 10^ lU of 
vitamin. administered intramuscularly have developed synçtoms of vita­
min D toxicity resulting in death, the same amount of vitamin D2 given 
intramuscularly to dairy cows does not result in any symptoms of vitamin 
D toxicity. The broad objective of this study will be to investigate the 
metabolism of vitamin D2 and vitamin D3 in ruminants. 
This dissertation is presented in an alternate dissertation format, 
including 2 manuscripts which have been submitted for publication in 
scientific journals. The first manuscript has been submitted to the 
European Journal of Biochemistry. The second manuscript has been sub­
mitted to the Journal of Nutrition. The format used for this dissertation 
is that of the Journal of Animal Science. A literature review precedes 
the first manuscript and a general summary and discussion follow the final 
manuscript. Literature cited throughout the dissertation is listed once, 
at the end of the dissertation. 
The doctoral candidate, Joel L. Sommerfeldt, was the principal in­




My doctorate research program developed as a result of parturient 
paresis prevention with vitamin D administration. Therefore, I will review 
extensively vitamin D metabolism as it relates to parturient paresis and 
only present a brief review of other previous research on parturient 
paresis. 
Parturient paresis is a metabolic disorder of dairy cattle associated 
with parturition and initiation of lactation. Reviews of parturient 
paresis are available (Braithwaite, 1976; Care et al., 1980; Green, 1980; 
Hibbs, 1950; Jonsson, 1978; Jorgensen, 1974; Kichura, 1981; Littiedike 
et al., 1981). Parturient paresis has been known by a number of names 
including milk fever, parturient hypocalcemia, parturient apoplexy, 
eclampsia, and paresis peurperalis (Littledike, 1974). 
Parturient paresis, on the basis of economical losses to dairymen, 
ranks among the top five diseases of dairy cattle (Anonymous, 1979). In 
1965, parturient paresis was estimated to cost dairymen in the United 
States 10.5 million dollars (Littledike, 1974); current costs would exceed 
20 to 30 million dollars per year (Bhattacharyya and DeLuca, 1973). Total 
economic losses from this disorder are difficult to determine because of 
many indirect costs associated with this disorder. Indirect costs include 
cows culled because of a history of parturient paresis, feed substituted 
during the dry period to prevent parturient paresis, decreased milk pro­
duction, secondary complications (i.e., mastitis, ketosis, nerve paralysis, 
split pelvis, ruptured gastrocnemius tendons, and degeneration and 
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necrosis of skeletal muscle), and additional mineral supplements to avoid 
parturient paresis (Littledike et al., 1981). 
Parturient paresis incidence is influenced by the age and breed of 
dairy cows. Jersey cows have two to five times greater incidence of par­
turient paresis than cows of other breeds (Hibbs et al., 1946a; Littledike, 
1974; Littledike et al., 1981). As the dairy cow becomes older, incidence 
of parturient paresis increases (Dyrendahl et al., 1970; Littledike, 1974; 
Littledike et al., 1981). Parturient paresis is uncommon before the third 
parturition, with incidence of parturient paresis greatest at the fifth to 
sixth parturition (Dyrendahl et al., 1970; Littledike, 1974; Littledike 
et al., 1981). The age effect is because of a number of factors including 
decreased absorption rates of calcium from the gut, decreased mobilization 
of calcium from bone, and increased milk production. 
In all cows, initiation of lactation is the main factor contributing 
to hypocalcemia (Littledike, 1974; Littledike et al., 1970, 1981). Only 
in cows developing severe hypocalcemia (usually about 50 to 60% of normal) 
does parturient paresis occur (Littledike, 1974; Littledike et al., 1970, 
1981). Parturient paresis develops usually within 24 h of parturition. 
Both plasma calcium and phosphorus concentrations decline at parturition, 
while magnesium concentration increases (Jorgensen, 1974; Littledike et al., 
1981). These changes and others associated with parturient paresis have 
been extensively reviewed (Littledike, 1974; Littledike et al., 1981) 
and will not be discussed here. 
At the initiation of lactation, when the mammary gland fills with 
milk, the calcium homeostasis mechanism is severely challenged, as the 
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inflow of calcium from the digestive tract is insufficient to provide the 
amount of calcium secreted into the milk. To prevent severe depletion of 
bone mineral content, dietary calcium intake and net absorption of calcium 
from the digestive tract are required. Dairy cows that are able to meet 
requirements for milk production do not develop parturient paresis, while 
dairy cows that are unable to do so develop parturient paresis. There­
fore, many researchers are evaluating methods to stimulate the activation 
of the calcium homeostasis mechanisms so that the cow can meet her cal­
cium needs during periods of greater calcium demands. 
Research to prevent parturient paresis has included adjusting pre-
partal dietary calcium and phosphorus intake (Beitz et al., 1974; Boda and 
Cole, 1954; Gardner and Park, 1973; Goings et al., 1974; Green et al., 
1981; Kendall et al., 1970; Kichura, 1981; Luick et al., 1957), greater 
prepartum grain feeding (Hibbs and Conrad, 1966; Kendall et al., 1966), 
feeding of acidic diets (Ender and Dishington, 1970), and administration 
of vitamin D and (or) its metabolites and related analogs (Capen et al., 
1979; Gast et al., 1979; Hibbs and Conrad, 1960, 1966, 1976; Jorgensen 
et al., 1978; Julien et al., 1977; Manston et al., 1981; Muir et al., 
1968; Sansom, 1978). Ever since the time vitamin D was first orally ad­
ministered to prevent parturient paresis (Greig, 1930), no known reports 
in the literature are available that have described the effect of the 
rumen and the microorganisms contained therein on vitamin D. This de­
ficiency of information is the basis for my doctorate research. 
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Vitamin D Administration to Prevent Parturient Paresis 
Orally - prepartum 
Research investigating vitamin D as a possible preventative for par­
turient paresis started in 1930 (Greig, 1930). Greig (1930) suggested 
feeding massive doses of vitamin D2 to dairy cows on each of 5 days pre­
partum to prevent parturient paresis. This recommendation was based on 
Greig*s (1930) initial studies in which he demonstrated an increase in 
plasma calcium concentration after feeding 5.0 x 10^ international units 
(lU) (1 in of vitamin D equals 25 ng) of vitamin D2 per day for 20 days 
to a cow. Hess et al. (1931, 1932) fed cows 3.0 x 10^ to 1.5 x 10^ lU of 
vitamin D2 per day in the form of irradiated yeast or irradiated ergo-
sterol. Vitamin D toxicity was not detected, but an increase in serum 
calcium and phosphorus concentrations were observed. 
Following these three initial studies, Hibbs and his coworkers at the 
Ohio Agriculture Experiment Station began many years of research in estab­
lishing guidelines to prevent parturient paresis with the administration 
of vitamin D. Hibbs and his coworkers (Hibbs et al., 1946a,b, 1951; Hibbs 
and Pounden, 1955, 1956) established the optimal time to orally administer 
vitamin D2 to prevent parturient paresis as 3 to 8 days prepartum. Hibbs 
and Conrad (1960) recommended 20 x 10^ lU of vitamin D2 to be fed daily 
for 3 to 8 days prepartum; this treatment decreased the incidence of par­
turient paresis because of the increase in serum calcium concentration 
above normal levels. The major deficiency of Hibbs' and Conrad's guide­
line is the ability to accurately predict the calving date. Swan (1952) 
evaluated the possibility of vitamin D toxicity when massive doses of 
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vitamin D2 were fed to dairy cows for more than 8 days as recommended by 
Hibbs and Conrad (1960). Vitamin D toxicity was not observed if a cow 
was fed 20 x 10^ lU of vitamin D2 per day for 10 days (Swan, 1952). 
Vitamin D toxicity, however, was detected if 20 x 10^ lU or more of vita­
min D2 was fed for longer than 10 days (Capen et al., 1965, 1966a,b; 
Cole et al., 1957; Hibbs and Pound en, 1955; Manston and Payne, 1964; 
Seekles et al., 1964). In summary, the guideline established for pre­
venting parturient paresis by massive prepartum oral administration is 
as follows. In dairy cows with a previous record of parturient paresis, 
feed 20 X 10^ lU of vitamin D2 per day for a minimum of 3 days prepartum 
and up to a maximum of 8 days prepartum. This system allows for an 82% 
protection against parturient paresis (Hibbs and Conrad, 1960; Hibbs and 
Pounden, 1955). 
Orally - continuously 
Because of the problem of accurately predicting the calving date, 
another regime to prevent parturient paresis was investigated. This re­
gime involved feeding vitamin D on a year-around basis. The rationale for 
this regime was based on the assumption that daily vitamin D feeding might 
help to maintain the available stores of calcium and, therefore, prevent 
parturient paresis (Hibbs and Conrad, 1966; Muir et al., 1968). Hibbs 
and Conrad (1966) fed 1.0 x 10^ to 5.8 x 10^ lU of vitamin D2 (irradiated 
dry yeast) on y ear-around basis to dairy cows with and without a previ­
ous record of parturient paresis. The continuous feeding of vitamin D2 
offered a 57% protection against parturient paresis to those cows with a 
previous record of parturient paresis; cows with no previous record of 
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parturient paresis were not protected by this method of vitamin D2 feed­
ing (Hibbs and Conrad, 1966, 1976). No signs of vitamin D toxicity in the 
dairy cows were observed. 
Intramuscular injections 
Another area of research investigating the prevention of parturient 
paresis involved the administration of vitamin D via subcutaneous (SC) 
or intramuscular (IM) injection. This method of vitamin D administration 
was chosen by Swan (1952) as he thought this method would be more popular 
among farmers than feeding vitamin D prepartum. Swan (1952) was the 
first investigator to administer vitamin D2 as SC or IM injections. Dairy 
cows were able to tolerate 20 x 10^ lU of vitamin D2 per day for 10 days 
if administered orally, but toxicity resulted if administered subcutane­
ous ly (Swan, 1952). Swan (1952) demonstrated a difference between oral 
administration and injections of vitamin ©£, though the significance of 
this was not realized at the time. In another experiment, a single injec­
tion (IM) of vitamin D3 (20 x 10^ lU) resulted in toxicity symptoms in 
dairy cows while the same dosage of vitamin D2 when fed to daiiry cows does 
not result in toxicity; in fact, a dairy cow can be fed 20 x 10^ lU of 
vitamin D2 per day for up to 10 days without toxicity occurring (Greig, 
1963; Littledike and Horst, 1982; Manston and Payne, 1964; Payne, 1963; 
Seekles et al., 1964). Therefore, a recommendation for parenteral adminis­
tration of vitamin D3 safely to prevent parturient paresis is a single IM 
injection of 10 x 10^ lU of vitamin D3 given 3 to 8 days prepartum (Greig, 
1963; Julien et al., 1977; Payne, 1968; Payne and Manston, 1967; Seekles 
et al., 1964; Tutt, 1963). 
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With the isolation and identification of vitamin D metabolites (to be 
discussed later) came the investigation of vitamin D metabolites and their 
analogs for the prevention of parturient paresis. The use of 25-hydroxy-
vitamin D3 (25-OH-D3) (Jorgensen et al., 1978; Olson et al., 1973a,b, 
1974; Sansom, 1978), 1,25-dihydroxyvitaniin D3 (1,25-(0H)2-D3) (Capen 
et al., 1979; Cast et al., 1979; Hoffsis et al., 1978; Sansom, 1978), and 
la-hydroxyvitamin D3 (la-0H-D3) (Bar et al., 1980; Gast et al., 1977; 
Jonsson, 1978; Manston et al., 1981; McMurray et al., 1980; Mullen et al., 
1979; Sansom, 1978) to prevent parturient paresis has been investigated. 
As in the case of administering vitamin D3, accurately predicting the date 
of parturition is a major problem. If the date of parturition is incor­
rectly determined, the incidence of parturient paresis actually can be 
increased (Hibbs and Conrad, 1976). 
Biological Activity of Vitamin D2 and 
Vitamin D3 in Ruminants 
Evidence that vitamin D2 and vitamin D3 are absorbed and (or) metabo­
lized differently has been demonstrated in the literature. Chen and 
Bosmann (1964) reported that chicks utilize vitamin D3 more effectively 
than vitamin D2. This observation was developed from a study that was 
based on research starting in the 1930s (Bills et al., 1935; Klein and 
Russell, 1931; Massengale and Nussmeier, 1930; Remp and Marshall, 1938; 
Russell et al., 1934; Steenbock et al., 1932) and has become an estab­
lished fact. Even though a difference in use of vitamin D2 and vitamin 
D3 in chicks was demonstrated, it has been assumed that vitamins D2 and 
Dg are metabolized similarly in nonavian species. Recent evidence in the 
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literature demonstrates, however, that this might not be true in both rumi­
nants and nonruminants (Horst et al., 1982; Hunt et al., 1967a,b, 1969, 
1972). Swan (1952) demonstrated that a cow could tolerate 10 x 10^ lU of 
vitamin D2 administered orally or intramuscularly without vitamin D2 
toxicity occurring. A cow, however, will display signs of vitamin D 
toxicity if 10 x 10^ to 50 x 10^ lU of vitamin are administered intra­
muscularly (Greig, 1963; Manston and Payne, 1964; Payne, 1963; Seekles 
et al., 1964). Hunt et al. (1967a,b, 1969, 1972) and Lehner et al. (1967) 
have demonstrated that vitamin D3 is significantly more active in New 
World monkeys (i.e., from the western hemisphere; e.g., squirrel monkey) 
than is vitamin D2 in promoting intestinal absorption of calcium and pre­
venting metabolic bone disease. Vitamin fed to Old World monkeys (i.e., 
from the eastern hemisphere; e.g., rhesus monkey) in toxic amounts will 
cause vitamin D toxicity leading to death, while vitamin D2 fed at the 
same dosages proved nontoxic (Hunt et al., 1972). Horst et al. (1982) 
also have demonstrated that the pig, rat, and chick discriminate in their 
metabolism of vitamin D2 and vitamin D3. 
Estrogen Degradation in the Rumen 
As has been stated previously, no reports are available in the litera­
ture describing the effect of ruminai microorganisms on dietary vitamin D. 
Because vitamin D is a secosteroid, a review of literature describing the 
effect of ruminai microorganisms on steroids and (or) related compounds 
seems useful. Such steroids that have received attention are estrogen 
and phyto-estrogenic-like substances in plants. Estrogenic substances 
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have been foimd in over 50 species of plants (Bradbury and White, 1954; 
Braden et al., 1971; Famsworth et al., 1975a,b; Livingston, 1978), with 
alfalfa and subterranean clover being the most thoroughly studied because 
of their extensive use in agriculture. 
Estrogenic substances that have been characterized in plants fit 
into one of three general chemical categories (Verdeal and Ryan, 1979). 
These categories include: (1) isoflavones, (2) coimestans, and (3) 
resorcyclic acid lactones (Verdeal and Ryan, 1979). 
Isoflavones are the most common, naturally-occurring isoflavonoids, 
with over 70 isoflavones and 40 isoflavone glycosides having been iso­
lated (Wong, 1975). Of the estrogenic isoflavones, the major confounds 
are genistein, formononetin, biochanin-A, and daidzein (Shutt, 1976; 
Verdeal and Ryan, 1979). These compounds, in total, can occur in concen­
trations as high as 5% of the dry matter of the plant (Shutt, 1976). 
Genistein and formononetin are the major isoflavones present in subter­
ranean clover, whereas only genistein appears in substantial quantities in 
alfalfa (Verdeal and Ryan, 1979). 
A second class of isoflavonoids that contains compounds possessing 
estrogenic activity is the coumestans (Verdeal and Ryan, 1979). Over 20 
naturally-occurring coumestans have been reported (Wong, 1975). The 
coumestans that have been studied thoroughly are the coumestans from 
alfalfa and ladino clover. The dominant coumestans in alfalfa is 
coumestrol (Verdeal and I^an, 1979). Other coumestans of lesser impor­
tance include trifolial, medicagol, 4'-methoxycoumestrol, S'-methoxy-
coumestrol, lucemol, and sativol (Verdeal and Ryan, 1979). 
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The third category of estrogenic substances in plants is the deriva­
tives of resorcyclic acid lactones, which are not compounds produced by the 
plant itself but are mycotoxins produced by mold associated with the plant 
(Verdeal and Ryan, 1979). The most common derivative is zearalenone, 
which is a mycotoxin that is synthesized by the mold Fusarium roseum, 
that can infect com, wheat, barley, sorghum, or hay (Hidy et al., 1977; 
Shutt, 1976). Zearalenone, also known as "fermentation estrogenic sub­
stance" or as F-2 toxin, can contaminate up to 10 to 20% of the marketable 
com and wheat (Stoloff et al., 1976). Zearalanol, a derivative of 
zearalenone, has been patented for use as a growth stimulant in animals 
under the trade name, Ralgro (Sharp and Dyer, 1972). 
The phyto-estrogens of plants are degraded in the rumen to inactive 
and (or) active compounds. The two isoflavones, genistein and biochanin A, 
are degraded in the rumen to give p-ethy1-pheno1 and a phenolic acid, 
neither of which are estrogenic (Braden et al., 1967; Cox and Braden, 
1974); therefore, genistein and biochanin A are inactivated by ruminai 
fermentation. These two isoflavones, genistein and biochanin A, are estro-
genically active if given intramuscularly (Braden et al., 1967; Cox and 
Braden, 1974). The isoflavone formononetin has little or no estrogenic 
activity itself but is demethylated in the rumen to give daidzen and subse­
quently reduced to yield equol, a weak estrogenically active compound 
(Batterham et al, 1971; Cox and Braden, 1974; Shutt et al. , 1970; Verdeal 
and Ryan, 1979). Coumesterol is rendered estrogenically inactive in the 
rumen because of the formation of less estrogenically active, but unidenti­
fied metabolites (Shutt, 1976). Little is known about the effect of 
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ruminai fermentation on zearalenone, except that zearalenone becomes es-
trogenically less active within the rumen (Verdeal and Ryan, 1979). In 
summary, the rumen microbes actively catabolize estrogen-like substances 
and this might imply that the rumen microbes catabolize vitamin D and 
vitamin D-like substances to compounds with greater or lesser biological 
activity. 
Intestinal Degradation of Steroids 
Another area of research that should be evaluated to aid in the under­
standing of the effect of ruminai microorganisms on vitamin D is intesti­
nal microbial metabolism. The rimien and the large intestine of all mamr-
mais studied demonstrate several functional similarities (Stevens et al., 
1980). The structure of both are designed to allow retention of digesta. 
Both provide a pH and fluid environment suitable for microbial digestion 
of carbohydrates and synthesis of protein and vitamins (Stevens et al., 
1980). Finally, the rumen and large intestine absorb volatile fatty acids 
(VFAs), recycle endogenous nitrogen, and aid in the conservation of endoge­
nous sodiim, chloride, bicarbonate, and water (Stevens et al., 1980). 
Steroids are metabolized extensively in the gut of rats (Bokken-
heuser et al., 1975, 1979). Comparison of the steroids excreted in the 
feces of germ^free rats with those in feces from conventional rats 
(Eriksson and Gustafsson, 1970a,b; Gustafsson and Sjovall, 1968a,b), to­
gether with studies of metabolism of steroids in mixed cultures of fecal 
or cecal flora of rats (Bjorkhem et al., 1971; Eriksson et al., 1968, 
1969, 1971), have demonstrated that the intestinal flora of the rats can 
convert steroids into a wide variety of metabolites (Bokkenheuser et al., 
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1975, 1981). Such conversions include hydrolysis of conjugates and 21-
dehydroxylation of corticoids (Bokkenheuser et al., 1979; Eriksson 
et al., 1969; Winter and Bokkenheuser, 1978; Winter et al., 1979). 
A primary reaction of intestinal bacteria on neutral steroids is the 
conversion of cholesterol to coprostanol (Rosenfeld et al., 1954; Snog-
Kjaer et al., 1956). This reaction results in the reduction of the 5,6-
double bond of cholesterol to form the saturated derivative coprostanol 
(Sadzikowski et al., 1977). An anaerobic, gram-positive diplobacillus 
that reduces cholesterol to coprostanol has been isolated from human 
feces and rat cecal contents (Eyssen et al., 1973; Sadzikowski et al., 
1977). This provides additional evidence that microbes of the intestinal 
tract (many species common to both the rumen and intestinal tract) are 
able to catabolize steroids and once again suggests that they might be 
capable of catabolizing vitamin D, also a steroid. 
Vitamin D Metabolism 
This review of vitamin D metabolism will not be exhaustive, because 
there are many excellent reviews already available (DeLuca, 1979a,b,c, 
1980; DeLuca et al., 1979; Fraser, 1980, 1981; Lawson and Davie, 1979; 
Norman, 1979; Norman and Henry, 1979; Norman and Ross, 1979). The field 
of vitamin D research is expanding at such a rate that this review will 
need to be modified in the near future to accommodate current research. 
It must be recognized that not a single vitamin D compound, but a family 
of vitamin D compounds, exhibits vitamin D activity (DeLuca, 1979b). The 
most inç)ortant vitamin D compounds are vitamin D2 and vitamin D3, to which 
this review will be limited. 
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Vitamin is produced by ultraviolet irradiation of the plant sterol 
ergosterol (DeLuca, 1979b). Vitamin Dg is produced in the skin by ultra­
violet irradiation of 7-dehydrocholesterol (DeLuca, 1979b; Holick and 
Clark, 1978). The metabolism of vitamin D2 and vitamin D3 seems similar 
(Jones et al., 1976); however, a difference in biological activity of 
vitamin D2 and vitamin D3 does exist (Borst et al., 1982; Hunt et al., 
1967a,b, 1969, 1972), as has been previously discussed. In the bird, 
vitamin D2 compounds are approximately 10 to 20% as active as their vita­
min D3 counterparts (Chen and Bosmann, 1964). 
New World monkeys also discriminate against vitamin D2 in terms of 
their biological response (Hunt et al., 1967a,b, 1969, 1972; Lehner et al., 
1967). The mechanism for this discrimination has not been determined yet. 
Vitamin D synthesized in the skin or absorbed from the small intes­
tine accumulates in the liver where it undergoes its first hydroxylation 
to yield 25-OH-D, the major circulating form of vitamin D (Blunt et al., 
1968). This hydroxylation is catabolized largely in the microsomes by a 
mixed-function monooxygenase dependent upon cytochrome P-450 (Bhatta-
charyya and DeLuca, 1974; Cinti et al., 1976; Fraser, 1980; Madhok and 
DeLuca, 1979). A mitochondrial 25-hydroxylase also exists, which seems to 
operate at greater substrate concentrations (Pedersen et al., 1979)- A 
limited regulatory mechanism is provided by 25-OH-D, which suppresses the 
25-hydroxylase (Bhattacharyya and DeLuca, 1973). The 25-OH-D, which cir­
culates at 20 to 40 ng per milliliter in the plasma (Fraser and Kodicek, 
1970; Haddad and Stamp, 1974; Horst et al., 1979b), seems not to act dir­
ectly on target tissue at physiological concentrations but is transported 
to the kidney, where it undergoes further hydroxylation. 
16 
In the kidney mitochondria, 25-OH-D is converted to 1,25-(0H)2-D» the 
most active foirm of vitamin D, by 25-OH-D-la-hydroxylase (lo-hydroxylase) 
(Fraser, 1980; Fraser and Kodicek, 1970). The system involved in this 
hydroxylation is a mitochondrial mixed-function monooj^genase (Fraser, 
1980; Ghazarian et al., 1974; Pedersen et al., 1976). The mechanism in­
volves renal ferredoxin reductase, renal ferredoxin, and a cytochrome 
P-450 (Fraser, 1980; Ghazarian et al., 1974; Pedersen et al., 1976). The 
final product, 1,25-(0H)2-D, is transported to the target tissues of in­
testine, bone, and elsewhere in the kidney. The renal la-hydroxylase 
is feedback inhibited by plasma calcium either directly or indirectly 
(Boyle et al., 1971; Garabedian et al., 1972; Henry et al., 1974; Omdahl 
et al., 1972). At normal plasma concentration of calcium, the renal la-
hydroxylase is only partially active. Hypocalcemia stimulates the renal 
la-hydroxylase, while hypercalcemia suppresses the renal la-hydroxylase. 
Evidence indicates that the hypocalcemic stimulation of the renal la-
hydroxylase is by way of the parathyroid gland (Fraser and Kodicek, 1973; 
Galante et al., 1972; Garabedian et al., 1972; Rasmussen et al., 1972). 
Parathyroid hormone (PTH) is transported to the target organs of the kid­
ney and bone. In the kidney, PTH stimulates phosphaturia, increases 
renal absorption of calcium, and stimulates the renal la-hydroxylase 
(DeLuca, 1979b,c; Fraser and Kodicek, 1973; Garabedian et al., 1972; 
Norman, 1979). In bone, PTH functions in concert with 1,25-(0H)2-D to 
stimulate the mobilization of calcium (DeLuca, 1979c; Eriksson et al., 
1968; Garabedian et al., 1974b; Norman, 1979). In the intestine, 
1,25-(0H)2-D, alone, stimulates the increased transport of calcium and 
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phosphate (Garabedian et al., 1974b). In this fashion, calcium concen­
tration in plasma is restored to normal, which decreases PTE secretion. 
24,25-Dihydroxyvitamin D (24,25-(0H)2-D), produced under conditions 
of normal calcium and phosphorus concentrations in plasma, is synthesized 
by hydroxylation of 25-OH-D by 25-0H-D-24-hydroxylase (24-hydroxylase) in 
kidney mitochondria (Knutson and DeLuca, 1974; Tanaka and DeLuca, 1974; 
Tanaka et al., 1975). Like la-hydroxylase, 24-hydroxylase is also a 
mixed-function monooxygenase (Madhok et al., 1977). The function of 
24.25-(0H)2-D is not completely understood (Tanaka et al., 1979); however, 
it does not seem to perform any of the known functions of vitamin D on 
intestinal calcium and phosphate transport, bone calcium mobilization, and 
renal reabsorption of calcium (DeLuca, 1979c). All of these activities 
are mediated by 1,25-(0H)2-D (DeLuca, 1979c). 24,25-Dihydroxyvitamin D 
may be required for normal embryonic development in birds (Henry and Nor­
man, 1978), a role in bone formation (Ornoy et al., 1978), maintenance of 
bone in a healthy state (Bordier et al., 1978; Kanis et al., 1978; Ornoy 
et al., 1978), and the suppression of PTE secretion (Henry et al., 1977). 
More research, however, is required to verify these suggested biological 
activities. 
Another dihydroxylated metabolite of vitamin D that was originally iso­
lated from the plasma of pigs (Suda et al., 1970) and identified as 25,26-
dihydroxylated vitamin D (25,26-(OH)2-D) also has been isolated from man 
and other species of animals (Horst et al., 1981; Mawer, 1977). While 
25.26-(0H)2-D can be produced in the kidney (Napoli et al., 1981; Tanaka 
et al., 1978), extrarenal sources of 26-hydroxylase have been demonstrated 
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(Garabedian et al., 1974a; Horst et al-, 1979a; Shepard et al., 1979). 
The exact biological function of 25,26-(0E)^-D is not known (Norman, 1979), 
with the exception that it might play a role in the mineralization of 
bone (Miravet et al., 1976) and increase the secretion of calcitonin 
(Care et al., 1981). More research is needed to elucidate and confirm 
the suggested biological functions of this metabolite. 
With the demonstration that the kidney had the capacity to 1-
hydroxylate and 24-hydroxylate 25-OH-D, it was not totally unexpected to 
discover that both hydroxylation processes could occur on the same sub­
strate to produce 1,24,25-trihydroxyvitamin Dg (1,24,25-(OH)3-D3) (Boyle 
et al., 1973; Holick et al., 1973). This metabolite is produced from 
either 24,25-(05)2-^3 or 1,25-(OH)2-D3 (Holick et al., 1973; Kleiner-
Bossaller and DeLuca, 1974; Tanaka et al., 1977). Research indicates 
that 1,24,25-(OE)3-D3 does not represent a further activation of 1,25-
(011)2-% is more likely a product leading to inactivation (Castillo 
et al., 1978; DeLuca, 1979b). 
Recently, Reinhardt et al. (1981a,b) isolated 1,25,26-trihydroxy-
vitamin D3 (1,25,26-(OH)3-D3), which is produced from either 25,26-(0H)2-
D3 or 1,25-(0H)2-D3 (Tanaka et al., 1981b). Biological function of 
1,25,26-(011)3-03 is unknown. 
Another development that is receiving attention is the discovery of a 
new and somewhat of a structurally unique vitamin D metabolite. This 
metabolite initially was encountered in the course of developing a compre­
hensive quantitative analysis scheme for all known vitamin D metabolites 
(Horst et al., 1979b). The metabolite was later identified as 25-hydroxy-
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vitamin 03-26,23 lactone (lactone) (Wichmann et al., 1979). Lactone has 
been found in the plasma of vitamin Dg-toxic pigs and cows (Horst, 1979), 
rats (Ohnuma et al., 1980), and other species of animals (Horst et al., 
1981). The metabolite 23,25-dihydroxyvitamin D3 (23,25-(0H)2-D3) (to 
be discussed later) seems to be a precursor of lactone (Hollis et al., 
1980; Tanaka et al., 1981a). A biological function for lactone has not 
been determined. 
In an attempt to elucidate the pathway of lactone biosynthesis, a 
new vitamin D metabolite was isolated and identified as 23,25-(0H)2-D3 
(Tanaka et al., 1981c). While its biological function is unknown, 23,25-
(0E)2-D^ seems to be a precursor for lactone (Tanaka et al-, 1981a); more 
research, however, is required to verify this. 
Other metabolites, 24-hydroxyvitamin (Wichmann et al., 1981a), 
25-hydroxy-24-oxovitamin D3 (Takasaki et al., 1980, 1981; Wichmann et al., 
1981b), 25-hydroxyvitamin D2-25-glucuronide (LeVan et al., 1981), 23,24,25-
trihydroxyvitamin D3 (Wichmann et al., 1981b), 24,25,26-trihydroxyvitamin 
D3 (Wichmann et al., 1981b), 23-dehydro-25-hydroxyvitamin D3 (Wichmann 
et al., 1981b), la-hydroxytetranor-vitamin D-23-carboxylic acid (calci-
troic acid, which results from the side-chain oxidation of 1,25-(0H)2-D3) 
(Esvelt et al., 1979), and 25,26,27-trinorvitamin D-carboxylie acid 
(cholacalcioic acid) (DeLuca and Schnoes, 1979) have been isolated and 
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INTRODUCTION 
Feeding massive doses (i.e., 20 to 30 x 10^ international units 
(lU) daily) to mature dairy cows for 3 to 8 days prepartian to prevent 
milk fever does not result in vitamin D toxicity (Hibbs and. Pounden, 
1955). Vitamin D toxicity was not seen until 10 to 11 days after the 
start of feeding these massive doses of vitamin D2 (Capen et al., 1966a). 
Injection of 12.5 to 40 x 10^ lU of vitamins D2 and intramuscularly 
(IM) into mature dairy cows, however, does result in vitamin D toxicity 
(Littledike and Horst, 1982; Swan, 1952). Therefore, an undescribed 
event must be taking place in the gastrointestinal tract of the cow that 
prevents vitamin D toxicity for the first 10 days of massive oral feed­
ing of vitamin Dg. 
Sheep and cattle metabolize estrogens and phyto-estrogens in the 
rumen to estrogenically-inactive substances (Braden et al., 1971; Cox and 
Braden, 1974). Likewise, ruminants may be capable of metabolizing vita­
min D in the rumen to inactive compounds and, for this reason, have the 
ability to consume massive doses of vitamin D without development of 
toxicity. 
To date, no studies have described the metabolism of vitamin D by 
rumen microbes. Therefore, the objectives of this study were to deter­
mine the extent of rumen microbial degradation of vitamins D2 and D3 and 
to isolate metabolic products of rumen microbial degradation of vitamins 
D2 and D3. 
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MATERIALS AND METHODS 
Apparatus 
High-performance liquid chromatography (HPLC) was performed on a 
Model LC-204 fitted with a Model 6000-A pumping system, U6K injection 
valve, and a Model 440 ultraviolet-fixed wavelength (254 or 313 nm) de­
tector^ . 
Absorption spectra of vitamin D compounds in 100% ethanol were deter­
mined by using a variable wavelength Beckman DB spectrophotometer. 
Plasma calcium (Ca) concentration was determined with a Perkin-Elmer 
Model 303 atomic absorption spectrophotometer (Willis, 1960). 
Liquid scintillation counting was done with a Beckman LS-8000 scin­
tillation counter. 
Sterols 
3 3 [3a- H]-Vitamin D2 and [3a- H]-vitamin D3 (1.2 Ci/mmol) were pre-
3 pared by the sodium boro-[ H]-hydride reduction of the a-tricarboxyliron 
complex of 3-ketovitamin D2 (Barton and Patin, 1976). 
[4-^^C]-Vitamin D3 (30 mCi/mmol) was purchased from Amersham^. 
3 3 [ H]-Vitamin D2 and [ H]-vitamin D3 were purified by chromatography 
as described in figure 1 before administration to the calves. Radio­
chemical purity of the labelled vitamin D2 and vitamin D3 was confirmed 
^Waters Associates, Milford, MA. 
2 Amersham, Arlington Heights, IL. 
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3 by HPLC on a Zorbax S il silicic acid column (.46 x 25 cm) developed in 
hexane/isopropanol (99/1) at a flow rate of 2 ml/min. 
In Vitro Rumen Incubations 
A fistulated steer, fed a maintenance diet of alfalfa hay and cracked 
corn, was used as the major source of rumen contents for the in vitro in­
cubations. Incubations also were performed using rumen contents from 
fistulated sheep and cows fed similarly. Samples of the rumen contents 
were obtained 4 to 6 h postfeeding through the ruminai cannula. Rumen 
contents were strained immediately through cheesecloth, kept at 38 C, and 
gassed with CO2 to maintain anaerobic conditions. Strained rumen fluid 
(20 ml) was transferred into Erlenmeyer flasks (50 ml) while gassing with 
CO2. At this point, the rumen fluid was divided into two parts: (1) 
sterilized (controls), prepared by autoclaving at 121 C and 15 psi for 
15 min, and (2) unsterilized. [^H]-Vitamin D2 and (or) [^H]-vitamin D3 was 
diluted with the corresponding unlabelled vitamin D2 or D3 and 400 yg of 
this mixture was added to the incubation flasks under CO2. Flasks were 
stoppered with Bunsen valves, mixed, and incubated for various lengths of 
time at 38 C in a water bath with constant shaking of 50 oscillations/min. 
Extraction and Chromatography 
After the incubation period, a total lipid extract (Bligh and Dyer, 
1959) of the rumen fluid was prepared. The extract was dried partially 
using a rotary evaporator and then dried completely under moving N2. 
DuPont Company, Wilmington, DE. 
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Rumen fluid lipid residue was solubilized in 1 ml of hexane/chloroform 
(9/1) and chromatographed on a Lipidex 5000 (Packard) column (.9 x 58 cm) 
developed in 100 ml of hexane/chloroform (9/1) followed with 100 ml of 
hexane/chloroform (1/1). Fractions (5 ml) were collected and subsampled 
for radioactivity determinations. Three major peaks of radioactivity were 
detected and tabbed Q, Rj, and R2. 
The region corresponding to the elution of the Q peak from the Lipi-
dex 5000 column (130- to 150-ml fraction) was collected and rechromato-
graphed on a celite (Baker)/silicic acid (Biorad) (1/1, w/w) column 
(.9 X 58 cm) developed in 50 ml of hexane/ethyl acetate (9/1) followed 
with 300 ml of hexane/ethyl acetate (4/1). Before chromatography, the 
celite and silicic acid were activated by drying at 110 C for 16 h. The 
region corresponding to the elution of the Q peak from the celite/silicic 
acid column (150- to 250-ml fraction) was collected and rechromatographed 
4 
on a Sephadex LH-20 column (.9 x 58 cm) developed in hexane/chloroform/ 
methanol (79/20/1). Peak Q from the Sephadex LH-20 column (40— to 80-ml 
fraction) then was chromatographed by HPLC on a Zorbax Sil silicic acid 
column (.46 x 25 cm) developed in hexane/isopropanol (96/4) at a flow 
rate of 2 ml/min. 
The major radioactive peak from the HPLC column (27- to 35-ml frac­
tion) was collected and chromatographed again by HPLC on a Zorbax Sil 
column (.46 x 25 cm) developed in methylene chloride/isopropanol (99/1) 
4 Pharmacia Fine Chemicals, Piscataway, NJ. 
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at a flow rate of 2 ml/min. This column resolved peak Q into two distinct 
radioactive and UV absorbing peaks. 
Peaks Ri and R2 from the Lipidex 5000 column were collected and re-
chromatographed onto a Sephadex LH-20 column (.9 x 58 cm) eluted with 
hexane/chloroform/methanol (68.5/30/1.5). The R peaks were collected and 
then chromatographed individually by HPLC using a Zorbax Sil column 
(.46 X 25 cm) eluted with hexane/isopropanol (89/11) at a flow rate of 
2 ml/min. 
Bone Mineral Mobilizing Activity 
Male albino rats^, 24 d old, were housed in hanging wire cages. The 
rats were fed a vitamin D-deficient diet with low Ca and normal phosphorus 
(P) concentrations (Ca: .02%; P: .3%^) ad libitum for 2 wk. These rats 
are referred to as "vitamin D-deficient" rats. The rise in plasma Ca 
of rats on a vitamin D-deficient, low Ca diet in response to vitamin D 
is considered to be an in vivo measurement of bone Ca mobilization 
(Hibberd and Norman, 1969). 
Vitamin Dg-Q^ (D3-Q1) and vitamin D3-Q2 (D3-Q2) isolated and purified 
from rumen fluid in vitro incubations were evaluated for biological 
activity. Vitamin D-deficient rats were given different doses of vitamin 
D3, D3-Qj^, and D3-Q2 in different combinations intravenously in 50 ^1 of 
Holtzman, Madison, WI. 
^Tekland Test Diets, Madison, WI. 
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95% ethanol (tables 1 and 2), with some rats being pretreated 6 h before 
this with D3-Q2 intraperitoneally. Rats receiving no vitamin D3, D3-Q1, 
or D3-Q2 were control rats. Rats were sacrificed at either 12 or 24 h 
after the administration, and heparinized (10 units/ml) blood was col­
lected for determination of plasma Ca concentrations by atomic absorption 
spectrophotometry (Willis, 1960). 
In Vivo Rumen Incubations 
Two Jersey bull calves, averaging 120 kg body weight, were utilized 
for in vivo rumen fluid incubations of vitamin D2 and vitamin D3. Calves 
were fed a diet of grain and alfalfa hay pellets. 
3 3 
Five hundred yCi of [ S]-vitamin D2 and 500 yCi of [ S]-vitamin D3 
were adsorbed individually onto soluble starch contained within a gelatin 
3 3 bolus. A bolus of [-^H]-vitamin D2 was administered to one calf with [ H]-
vitamin D3 being administered to the other calf. Twenty-four hours later, 
calves were administered a second dose of 500 yCi of [^H]-vitamin D2 or 
[^H]-vitamin D3 diluted with 1 x 10^ lU of the corresponding unlabelled 
vitamin D2 or vitamin D3. Calves were sacrificed 72 h after the second 
administration. Rumen contents and heparinized (10 units/ml) blood were 
collected. Plasma was separated from blood cells by centrifugatxon at 
1500 g at 4 C and stored at -15 C until analyzed. Rumen fluid was ex­
tracted (Bligh and Dyer, 1959) and chromatographed exactly as described 




In Vitro Rumen Incubations 
The elution profile from the Lipidex 5000 column of end products of a 
24-h in vitro degradation of [^H]-vitamin Dg by rumen microflora is shown 
in figure 3. Seventy-five percent of the added vitamin was degraded in 
the nonsterilized rumen fluid as compared to the sterilized rumen fluid 
(control), which had a similar amount of added vitamin Dg. As the vitamin 
Dg was degraded in vitro, peaks Q, R^, and R2 were produced in the non-
sterilized rumen fluid. Both sterilized and nonsterilized rumen fluid had 
a radioactive peak comigrating in the region of peak Q. The radioactive Q 
peak in the sterilized rumen fluid, however, did not show a time—dependent 
appearance as did the Q peak in the nonsterilized rumen fluid. The time-
dependent appearance of Q, in addition to the fact the Q peak in steri­
lized rumen fluid did not comigrate with the Q peak of nonsterilized rumen 
fluid on celite/silicic acid (see figure 6), suggests that appearance of 
peak Q in sterilized rumen fluid was not microbial-dependent. 
3 Figures 4 and 5 show the time-dependent disappearance of [ H]-vitamin 
3 
Dg and the appearance of [ H]-metabolites Q, Rj, and R2 in the nonsteri-
3 lized and sterilized rumen fluid incubations, respectively. [ H]—Vitamin 
D3 did not disappear nor did any of the radioactive metabolites appear in 
3 the control incubations. Both the disappearance of [ S]-vitamin Dg and 
appearance of microbial [^Hj-metabolites appeared to be Tnavi-ninni at 24 h. 
A similar elution profile to figure 3 was elicited for a 24-h in 
vitro degradation of [^E]-vitamin D2 by rumen microflora (data not shown). 
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To eliminate the question of tritium exchange occurring, [-vitamin 
D3 used in an in vitro incubation gave similar results to those of the 
tritium-labelled vitamins D2 and D3 (data not shown). 
Peak Q from the Lipidex 5000 column (figure 3) from both sterilized 
and nonsterilized rumen fluid was isolated and chromatographed on a 
celite/silicic acid column (figure 6). The major peak (peak Q) from non-
sterilized rumen fluid contained 70 to 80% of the added radioactivity 
and was not present in sterilized rumen fluid extracts. Peak Q from the 
celite/silicic acid column was further purified by Sephadex LH-20. One 
major peak was observed (figure 7). After further purification by HPLC, 
peak Q "split" into two peaks that were tabbed Qj^ and Q2 (figure 8). 
Radioactivity was associated with both DV absorbance peaks. Peaks Qi 
and Q2 were collected together and further purified by HPLC with methylene 
chloride/isopropanol (99/1) (figure 9). Complete separation occurred on 
this column (figure 9). 
The individual and peaks were collected, and TJV spectra of the 
two metabolites that had been dissolved in 100% ethanol were obtained 
(figure 10). Ultraviolet spectra showed a Xmax for of 308 nm and Amax 
for Q2 of 310 nm, with both Qj and Q2 having a Xmin of 250 nm. The molar 
extinction coefficients (determined from the specific activity of the 
[-vitamin D3 used) were 9,600 for and 14,530 for Q2. 
The R peaks from the Lipidex 5000 column (figure 3) were isolated and 
chromato graphed in series by Sephadex LH-20, celite/silicic acid, and HPLC. 
After HPLC purification, the two radioactive peaks (R^ and R2) were not 
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associated with a UV-absorbing peak (data not shown). Therefore, no fur­
ther studies were conducted with these compounds. 
Bone Mineral Mobilizing Activity 
The results in tables 1 and 2 report the bone Ca mobilization in vita­
min D-deficient rats after intravenous administration with vitamin Dg, , 
or Q2, either individually or in combination with one another. Vitamin D3 
raised plasma Ca concentration, while Q2 had just a slight effect on Ca 
concentration. Conflicting results were obtained when Q2 was administered 
in combination with vitamin D3. Low amounts of or Q2 seemed to de­
crease the bone Ca mobilization capability of vitamin D3. Greater amounts 
of Q2 increased vitamin D^'s bone Ca mobilization capability. 
In Vivo Rumen Incubations 
Equal amounts (1.1 x 10^ lU) of unlabelled vitamin or vitamin 
3 
were fed to calves in combination with 800 uCi of the corresponding [ H]-
vitamin D2 or [^H]—vitamin Dg to assay for the in vivo production of the 
vitamin D metabolites demonstrated in the previously described in vitro 
experiments. The elution profiles (data not shown) from the Lipidex 5000 
column elicited by the rumen fluid collected from two calves administered 
3 9 [ H]-vitamin D2 and [ H]-vitamin were similar to that of the in vitro 
incubations (figure 3). Peak Q isolated from the two calves comigrated 
with peak Q isolated from the in vitro rumen incubations on Lipidex 5000, 
celite/silicic acid, Sephadex LH-20, and HPLC Zorbax Sil silicic acid col­
umns. Figure 11 is the elution profile of and Q2 isolated from the 
3 
rumen fluid of a calf administered [ H]-vitamin D^. 
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Peak Q2 also was isolated from blood plasma of calves administered 
[^H]-vitamin D2 and [^H]-vitamin D3. Peak Q2 from the plasma of calves co-
migrated with peak Q2 isolated from the in vitro incubation on the HPLC 
systems described in figure 2. In the final HPLC system, Qj and Q2 were 
isolated from plasma and chromato graphed by HPLC on a Zorbax Sil silicic 
acid column, with the metabolites being monitored at 254 nm and 313 nm. A 
standard solution containing snd Q2 isolated from in vitro rumen incu­
bations was chromatographed on this system. As depicted in figure 12, the 
ratio of at 313 nm/254 nm is 5.4, while Q2 is 10.9. When Qj^ and Q2 
from the plasma was chromatographed on this system (figure 13) , the 
313/254 ratio for Qj was low (4.0), while the 313/254 ratio for Q2 (11.1) 
compared very well to the ratio for the standard Q2. 
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DISCUSSION 
This report provides the first evidence that vitamin D2 and vitamin D3 
are metabolized by rumen microbes. The metabolites produced, tabbed , Q2» 
R]^, and R2, are chromatographically more polar than vitamin D. Of these 
four metabolites, only Q2 was found to circulate in the plasma of dairy 
calves dosed with -vitamin D^. Q2, therefore, represents the first re­
ported vitamin D3 metabolite generated by rumen microbial action that cir­
culates in bovine plasma. Whether this phenomenon occurs in the gastro­
intestinal tract of monogastrics is unknown. Many of the functions served 
by the rumen, however, are provided by the cecum and colon of other mammals, 
such as the pig and horse (Stevens et al., 1980). Therefore, the possi­
bility also exists for the presence of microbial vitamin D3 metabolites in 
monogastrics. 
The presence of Q2 in vivo prompted studies to determine its in vivo 
bone resorbing capacity in rats. Data in table 1 show that Qg did not 
promote bone Ca resorption. Antivitamin D-like activity, however, was ob­
served when equal amounts (w/w) of Q2 and vitamin D3 were injected into 
rats. This observation suggests that the ruminai metabolism of vitamin D 
acts as a detoxification process for animals consuming large quantities of 
vitamin D. Credence is lent to this hypothesis when considering the two 
following observations. Firstly, Littledike and Horst (1982) observed 
that 75% of cows treated intramuscularly 20 to 30 days before parturition 
with 17.5 to 20 x 10^ lU of vitamin D3 died within a few weeks. Secondly, 
Hibbs and Pounden (1955), however, were able to feed 20 to 30 x 10^ ID of 
vitamin D2 for up to 7 d before parturition without any sign of toxicity. 
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Protection against vitamin D toxicity from large oral doses probably oc­
curred as a result of rumen degradation of vitamin D as well as its con­
version by rumen microflora to possibly some "antivitamin D" compounds. 
Probably only little vitamin D undergoes similar microbial conver­
sion in monogastrics because most of the ingested vitamin D will have 
been absorbed before reaching the areas of anaerobic fermentation in the 
cecum and large intestine. Presence of the rumen, therefore, represents 
a major control point in vitamin D metabolism of ruminants. A control 
point at the rumen level may have significant survival value because the 
ruminant evolved as a grazing animal. Ruminants, therefore, have oppor­
tunity for prolonged exposure to sunlight as well as the opportunity to 
consume large quantities of irradiated plants. Holick et al. (1981) re­
cently have shown that overirradiation of rat skin leads to a plateau in 
conversion of 7-dehydrocholesterol to previtamin Dg and results in the 
formation of inactive vitamin Dg compounds. This protection mechanism, 
in combination with the partial degradation of the vitamin D2 of irradiated 
plants in the digestive tract, may have resulted in an effective means of 
protecting the early evolving ruminant from vitamin D toxicity. 
3 3 
Figure 1. Purification scheme for [ E]-vitamin and [ H]-vitamin D^. 
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Figure 2- Isolation and purification scheme for ruminai metabolites Q 
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HPLC-SILICIC ACID (.62 X 25 CM) (254 NM) 
HEXANE:ISOPROPANOL 
(99:1—•83:17) (.5 H) 
(99:1—•83:17) (3 H) 
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Figure 3. Elution profile of a 24-h in vitro rumen fluid incubation of 
[^H]-vitamin Dg from a Lipidex 5000 column (.9 x 58 cm). The 
Lipidex 5000 column was eluted with 100 ml of hexane/chloroform 
(9/1) followed with 100 ml of hexane/chloroform (1/1). Forty 
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Figure 4. Time-dependent disappearance profile of [^H]-vitamin Dg 
incubated 24 h in vitro with sterilized or nonsterilized 
rumen fluid. Results are expressed as a percentage of 
initial radioactivity of [^H]-vitamin D3 left after speci­
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Figure 5. Time-dependent appearance profiles of peaks Q, R]^, and R2 
from a 24-h in vitro rumen fluid (sterilized and nonsteri-
lized) incubation of [^H]-vitamin D3. Results are expressed 
as a percentage of the initial radioactivity of [%]-vitamin 
D3 in the incubation. 
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Figure 6. Elution profile of peak Q, isolated from the Lipidex 5000 
column (figure 3), chromatographed on a celite/silicic acid 
column (.9 x 58 cm). The celite/silicic acid column was 
eluted with 50 ml of hexane/ethyl acetate (9/1) followed with 
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Figure 7. Elution profile of peak Q, isolated from the celite/silicic 
acid column (figure 6), chromatographed on a Sephadex LH-20 
column (.9 X 58 cm). The Sephadex LH-20 column was eluted 
with 120 ml of hexane/chloroform/methanol (70/20/1). Twenty-
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Figure 8. Elution profile of peak Q, isolated from the Sephadex LH-20 
column (figure 7), chromatographed by HPLC on a Zorbax Sil 
column (.45 x 25 cm). The Zorbax Sil column was eluted with 
hexane/isopropanol (96/4) at a flow rate of 2 ml/min. Two-ml 
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Figure 9. Elution profile of the combined peak and Q2, isolated by 
HPLC on a Zorbax Sil colimn (figure 8), chromatographed by 
HPLC on a Zorbax Sil column (.45 x 25 cm). The Zorbax Sil 
column was eluted with methylene chloride/isopropanol (99/1) 
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Figure 10. Ultraviolet spectra of Qj and Q2 that were purified from 
rumen fluid in vitro incubations. Absorption maxima and 
minima were: Xmax = 308 cm and Xmin — 250 nm for Q^; 
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Figure 11. Elution profile of peak and Q2 that were isolated 
from the rumen fluid of a calf given [%]-vitainin D3, 
chromatographed by HPLC on a Zorbax Sil column (.45 x 
25 cm). Chromatography procedure the same as that used 





Q|# = 5.4 
.005-
.004-




ELUTION VOLUME (ml) 
Figure 12. Elution profile of and Q2, purified from in vitro rumen 
fluid incubations of [^H]-vitamin D, chromatographed by HPLC 
on a Zorbax Sil column (.45 x 25 cm). The Zorbax Sil column 
was eluted with methylene chloride/isopropanol (99/1) at a 
flow rate of 2 ml/min. The eluant was monitored at 254 nm 
and 313 nm. Two-ml fractions were collected. 
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Figure 13- Elution profile of Qj and Q2, isolated from calves plasma. 
Chromatography procedure was the same as that used in 
figure 12. The calves were administered [^H]-vitaniin B3. 
I 
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TABLE 1. BONE CALCIUM MOBILIZATION IN VITAMIN D-DEFICIENT 
RATS AFTER INTRAVENOUS ADMINISTRATION WITH VITAMIN 
D3 AND (OR) 02 
Treatment Pretreatment^ Plasma Ca^ 
D3 Q2 Q2 
^ - - - 3.4 ± .1^ 
25 - - 4.2 ± .1* 
25 25 - 4.1 ± .1* 
25 25 25 4.2 ± .1* 
25 125 - 4.0 ± .2 
25 125 125 4.5 ± .1* 
— — — 4.1 È .1 
250 - - 5.8 ± .2* 
250 250 250 5.1 ± .2* 
250 250 4.8 ± .1* 
250 750 750 5.6 ± .3* 
^ — — 4.3 ± .2 
250 - - 6.5 ± .3* 
250 250 - 5.6 ± .2* 
250 - 4.3 ± .1 
^Pretreatment was 6 h before treatment with vitamin D3 and Cor) Q2. 
^Blood collected 24 h after treatment with vitamin D3 and (or) Q^. 
""Ajupunt of vitamin D3 or Q2 administered to each rat.. 
Value is mean ± SEM for 6 rats/group. A, B, C are three individual 
experiments. 
Group of rats that received no D3 or Q2 are controls- Those data 
with asterisk differ (p < .05) from control. 
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TABLE 2. BONE CALCIUM MOBILIZATION IN VITAMIN D-DEFICIENT 











d 3.6 ± .1 
4.5 ± .2 
4.8 ± .2" 
3.6 ± .1 
5.8 ± .T 
5.6 ± .r 
^retreatment was 6 h before treatment with vitamin D3 find for) 
^Blood collected 12 h or 24 h after treatment with vitamin D3 
and (or) Qj. 
'"Amount of vitamin D3 or Q2 administered to each rat. 
Value is mean ± SEM for 6 rats/group. 
*Group of rats that received no D3 or Qj are controls- Those data 
with asterisk differ (p < .05) from control. 
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SECTION II. 
METABOLISM OF ORALLY ADMINISTERED [^H]-VITAMIN D2 AND 
[3H]-VITAMIN D3 BY DAIRY CALVES 
12 3 
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INTRODUCTION 
Milk fever, or parturient paresis (PP), a metabolic disorder of lac-
tat ing dairy cows, has been investigated extensively over the last 50 yr. 
One method to prevent PP that has received much attention involves the 
prepartal administration of vitamin D. Hibbs and his coworkers (Hibbs 
and Conrad, 1960; Hibbs and Pounden, 1955, 1956; Hibbs et al., 1946a,b, 
1951) established the following guideline to decrease the incidence 
of PP. In dairy cows with a previous record of PP, feed 20 x 10^ lU 
of vitamin D2 per day 3 to 10 days prepartum. This guideline was es­
tablished in the 1950s; however, since then no reports other than those 
of our preliminary reports (Sommerfeldt et al., 1980, 1981) have 
described the ruminai metabolism of vitamin D fed to ruminants. 
Sommerfeldt et al. (1980, 1981) demonstrated that both vitamin D2 
and vitamin D3 are degraded in the rumen. New, unidentified metabolites 
are produced from this degradation of vitamin D. In addition, another 
group of steroids, plant estrogens, are degraded in the rumen to less 
biologically active metabolites (Braden et al., 1967; Cox and Braden, 
1974; Shutt, 1976; Verdeal and Ryan, 1979). Steroids, such as cholestér­
ols, are degraded partially in the intestinal tract of animals (Bokken-
heuser et al., 1975, 1979; Rosenfeld et al., 1954; Sadzikowski et al., 
1977; Snog-Kjaer et al., 1956), which gives additional evidence that 
perhaps vitamin D also would be degraded in the rumen. 
Hunt et al. (1967a,b, 1969, 1972) have shown that vitamin D2 and 
vitamin D3 do not have the same biological activity in New World monkeys. 
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They found vitamin Dg to be significantly more active in promoting in­
testinal absorption of calcium and preventing metabolic bone disease. 
Horst et al. (1982) have found that rats, pigs, and chickens also demon­
strate a difference in the metabolism of vitamin D2 and vitamin D3. 
Ruminants also metabolize vitamin D2 and vitamin D3 differently. While 
dairy cows administered 20 x 10^ lU of vitamin D3 intramuscularly have 
shown vitamin D toxicity resulting in death, the same amount of vitamin 
D2 given intramuscularly to dairy cows does not result in any vitamin D 
toxicity (Greig, 1963; Littledike and Horst, 1982; Manston and Payne, 
1964; Payne, 1963; Seekles et al., 1964; Swan, 1952). The objective of 
3 this study, therefore, was to evaluate the metabolism of [ S]-vitamin D2 
and of [^H]-vitamin D3 orally administered to dairy calves. 
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MATERIALS AND METHODS 
Apparatus 
High-performance liquid chromatography was performed on a Model 
LC-204 fitted with a Model 6000-A pumping system, U6K injection valve, a 
Model 440 ultraviolet-fixed wavelength (254 or 313 nm) detector, and a 
Model 660 solvent programmer^. 
The spectra of all vitamin D compounds dissolved in 100% ethanol were 
determined using a variable wavelength Beckman DB spectrophotometer. 
Liquid scintillation counting was done with a Beckman LS-8000 scintil­
lation counter. 
Sterols 
3 o [3a- H]-Vitamin D2 and [3a—^H]-vitamin D3 (1 to 2 Ci/mmol) was pre­
pared by the sodium boro-[^H]-hydride reduction of the o-tricarboxyliron 
complex of 3-ketovitamin D2 (Barton and Patin, 1976). 
[^H]-Vitamin D2 and [^H]-vitamin D3 were purified by chromatography 
as described in figure 1 before administration to the calves. Purity of 
the labelled vitamin D2 and vitamin D3 was determined by HPLC on a Zorbax 
Sil silicic acid column (.46 x 25 cm) developed in hexane/isopropanol 
(99/1). 
^Waters Associates, Milford, MA. 
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Animals and Vitamin D Administration 
Six Jersey bull calves, averaging 100 kg, were fed a diet of alfalfa 
3 hay pellets and concentrate. Three hundred sixty-two pCi of [ H]-
3 
vitamin D2 and 362 yCi of [ H]-vitamin dissolved in 100% ethanol were 
individually incorporated onto soluble starch contained within a gelatin 
3 bolus. A bolus of [ E]-vitamin D2 was administered to each of three 
3 
calves while a bolus of [ H]-vitamin D3 was given to each of the other 
three calves. Heparinized (10 units/ml) blood was collected from the 
calves 14 times over a 24-d period after the administration of the labelled 
vitamin D. 
Extraction and Chromatography 
A total lipid extract (Bligh and Dyer, 1959) of 25 ml of plasma was 
prepared. The extract was dried using a rotary evaporator, solubilized 
in 3 ml of hexane/ethyl acetate (99/1), and then chromatographed on a 
celite (Baker)/silicic acid (Biorad) (1/1, w/w) column (1.8 x 10 cm) de­
veloped in hexane/ethyl acetate (99/1). Before chromatography, the celite 
and silicic acid were activated by drying at 110 C for 16 h. The sample 
was eluted with two column volumes of hexane/ethyl acetate (99/1). Two 
column volumes of a second solvent (chloroform/methano1, 1/1) were passed 
through the column to elute vitamin D and its metabolites. The eluent was 
evaporated to dryness under moving N2; the residue was dissolved in 250 pi 
of hexane/isopropanol (99/1). The resulting solution was chromatographed 
by HPLC on a Zorbax Sil silicic acid column (.62 x 25 cm). A gradient 
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solvent programmer was used, beginning with the initial solvent of 
hexane/chloroform (99/1). After a 2-h program run, the final solvent 
of hexane/chloroform (83/17) was achieved. Three-ml fractions were col­




Calves were fed [ H]-vitamin D2 or [-^H]-vitamin to evaluate the 
metabolism of these two vitamins. Total plasma radioactivity peaked at 
•o 3 
80 h after administration of [^H]-vitamin Dg and [ H]-vitamin to the 
calves; total radioactivity steadily decreased thereafter (figure 1). 
Total radioactivity in the plasma of calves administered [^E]-vitamin D2 
peaked at 4600 dpm/ml of plasma, while the total radioactivity in plasma 
of calves administered [^B]-vitamin D3 peaked at 8400 dpm/ml of plasma. 
3 An assay was developed to isolate [ H]-vitamin D and its metabolites 
3 3 from the plasma of calves administered either [ H]-vitamin D2 or [ H]-
vitamln D3. Blood plasma (25 ml) extracted with methanol/chlorofoirm and 
partially purified on a celite/silicic acid column was chromatographed by 
HPLC on a silicic acid column. A gradient solvent system was used to 
accommodate complete separation in one chromatographic step of vitamin D 
and its metabolites and the two metabolites (Qj and Q^) produced in the 
rumen. The elution profile, from the above described HPLC, of vitamin D3 
and its metabolites in blood plasma, including those metabolites produced 
in the rumen (Q^ and Q2), is shown in figure 2. The gradient solvent sys­
tem described for this HPLC was utilized because it provided optimal 
separation of 25-hydroxyvitamin D (25-OH-D), Qj, Q2, and 24,25-dihydroxy-
vitamin D (24,25-(OH)2-D). 
o 3 
The appearance and disappearance profiles of [-^E]-vitamin D, [ H]-
25-OH-D, [^H]-24,25-(0H)2-D, [^E]-25,26-dihydroxyvitamin D ([^E]-25,26-
(0H)2-D), and [%]-l,25-dihydro3qrvitamin D ([%]-!,25-(0H)2-D) in the 
calves plasma are shown in figures 3 and 4. In both treatment groups. 
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3 [ E]-vitamin D peaked at 24 to 48 h and was the predominant labelled com-
3 pound in the calves plasma 10 to 15 h after oral administration of [ H]-
3 3 
vitamin D2 or [ H]-vitamin D^- After 10 to 15 h, [ H]-25-OH-D became the 
predominant labelled vitamin D metabolite, reaching its maximal concentra­
tion at 48 to 96 h after [^H]-vitamin D administration in both groups of 
3 
calves. The appearance and disappearance profiles of [ H]-25,26-(0B)2-D 
and [^H]-1,25-(0H)2-D (figure 4) paralleled the profile elicited for [^H]-
25-OH-D (figure 3). As was the case with total radioactivity appearance 
in the plasma, the amount of [^E]-vitamin D, [^B]-25-OB-D, [^H]-24,25-
(0E)2-D, and [2b]-1,25-(0B)2-D arising in [^H]-vitamin D2-treated calves 
3 
was two- to fourfold less than the appearance of these metabolites in [ H]-
vitamin D3-treated calves; [%]-25,26-(OB)2-D was nondetectable in the 
[^E]-vitamin E^-treated calves. 
In addition to the known vitamin D metabolites, four unidentified 
radioactive peaks appeared in the plasma (figure 5). Two of these peaks 
seemed identical to peaks Qj and Q^, which result from rtmen microbial 
vitamin D degradation (Sommerfeldt et al., 1980, 1981). The two other 
unidentified peaks, labelled peak 1 and peak 2, elicited profiles (figure 
3 6) in the plasma that paralleled the profiles demonstrated for [ E]-vita-
min D and [ B]-25-0B-D, respectively. Peak 1 isolated from the plasma of 
^ 3 [•^B]-vitamin D2-treated calves was nondetectable in the [ E]-vitamin D^-
3 treated calves. Peak 2 isolated from the plasma of [ E]-vitamin D3-
3 treated calves was nondetectable in the [ H]-vitamin D2-treated calves. 
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DISCUSSION 
The results from this study indicate that vitamin D2 and vitamin D3 
are not metabolized identically when orally administered to dairy calves. 
Twice the amount of [^Hj-vitamin Dg and [^H]-vitamin D3 metabolites appear 
in the plasma when compared to [%]-vitamin D2 and [%]-vitamin D2 metabo­
lites. In addition, [\]-25-0H-D, [^H]-1,25-(0H)2-I>, [%l-24,25-(0H)2-B, 
and [%]-25,26-(0H)2-D arising from [^S]-vitamin I^-treated calves were 
two- to fourfold less in quantity than the amount of these metabolites in 
[^H]-vitamin D^-treated calves. These findings are in contrast to the cur­
rently accepted dogma that vitamin D2 and vitamin D3 are metabolized simi­
larly in nonavian species. Results from this study, however, are in 
agreement with other research workers who also have detected differences 
in metabolism of vitamin D2 and vitamin Dg in New World monkeys (Hunt 
et al., 1967a,b, 1969, 1972), rats, pigs, chicks (Horst et al., 1982; 
Littledike and Horst, 1982; Swan, 1952), and dairy cows. This study indi­
cates that cattle discriminate against vitamin D2 and its metabolites in 
favor of the vitamin D3 form. Also, we estimate that oral vitamin has 
only one-half the activity of oral vitamin D3 (per unit weight) in ruminants. 
The results from this study will be especially relevant to the animal 
industry. Vitamin D requirements for daiiry cattle (National Research 
Council (NRC), 1978) are based on initial studies conducted in the 1930s 
and 1940s (Bechdel et al., 1938; Rupel et al., 1933; Wallis, 1944) and 
further evaluated in the 1970s (Dobson and Ward, 1974; Ward et al., 1971, 
1972). The vitamin D requirements are based on studies conducted with 
60 
both vitamin D2 and vitamin Dg, with the NRC requirements not differenti­
ating between these two vitamins with regards to vitamin D activity. 
Therefore, vitamin D supplementation procedures for dairy cattle will re­
quire re-evaluation in view of the results of this study. Supplementation 
of the diet thus should require less vitamin Dg than vitamin D2 to obtain 
similar plasma concentration of the two forms of vitamin D. In addition, 
the difference in biological activity noted between vitamin D2 and vitamin 
D3 must be considered when treating ruminants for vitamin D-related dis­
orders because less vitamin D3 than vitamin D2 probably would be required 
in the treatment or prevention of these disorders. The possibility of 
vitamin D toxicity, however, is much greater with vitamin D3 than vitamin 
D2. While a ruminant is able to tolerate an excessive amount of vitamin 
D2, the same amount of vitamin D3 has greater biological activity in rumi­
nants than does vitamin D2-
This study presents additional evidence that vitamin D is degraded in 
the rumen and two of the metabolites produced from this degradation are 
absorbed and circulate in the plasma. The function of these metabolites is 
unknown. In addition, two unidentified peaks appear in the plasma that 
have not been isolated from calves before this. While the two radioactive 
peaks seem not to be rumen metabolites, but metabolites of either vitamin 
D or 25-OH-D, more research is needed to identify these peaks and deter­
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Figure 1. Appearance and disappearance profile of total radioactivity 
in the plasma of [^Hl-vitamin D2 and [^E]-vitamin D^-treated 
calves- Each point is the mean of three calves ± SEM. 
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Figure 2. Elution profile of a standard solution containing vitamin Dj 
and its metabolites developed by HPLC with a Zorbax Sil col­
umn (.62 X 25 cm). Metabolites Qj and Q2 are produced from 
the cat aboli sm of vitamin D in the rumen. A gradient solvent 
programmer was used, beginning with the initial solvent of 
hexane/chloroform (99/1). After a 2-h program run at a flow 
rate of 3 ml/min, the final solvent of hexane/chlorofofm (83/17) 
was achieved. 
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Figure 3. Appearance and disappearance profile of [ H]-vitainin D and 
[3H]-25-0H-vitamin D in the plasma of [^ HJ-vitamin D2 and 
[%]-vitamin D^-treated calves. Each point is the mean of 
three calves ± S EM. Same chromatographic system as described 
in legend of figure 2 was used. 
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Figure 4. Appearance and disappearance profile of [%]-24,25-(0H)2-
vitamin D, [3H]-25,26-(0H)2-vitamin D, and [%]-l,25-(0H)2-
vitamin D in the plasma of [%]-vitamin D2 and [3E]-vitamin 
Dg-treated calves. Each point is the mean of three calves ± 
SEM. Same chromatographic system as described in legend of 


























Figure 5. Elution profile of a calf plasma sample taken 80 h after 
administration of [^HJ-vitamin D3. Peaks 1 and 2 are un­
identified metabolites of vitamin D. Same chromatographic 
system as described in legend of figure 2 was used. 
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Figure 6. Appearance and disappearance profile of [ H]-peak 1 and [%]-
peak 2 (see figure 3) in the plasma of [%]-vitamin D2 and 
I^S]-vitamin Dg-treated calves. Each point is the mean of 
three calves ± SEM. Same chromatographic system as described 
in legend of figure 2 was used. 
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SUMMARY AM) DISCUSSION 
Vitamin D has been utilized since 1930 for the prevention of parturi­
ent paresis in dairy cows. In this time span, however, there are no known 
reports in the literature describing the effect of the rumen on vitamin D. 
As discussed previously, steroid compounds are known to be degraded in 
both the rumen and intestinal tract. Therefore, it followed that perhaps 
vitamin D also is degraded in the rumen. 
The studies in Section 1 are the first evidence that vitamin D is 
catabolized in the rumen. Four previously unidentified metabolites of 
vitamin D are produced from the catabolism of vitamin D in the rumen. 
This was demonstrated first in vitro in dairy cows, steers, calves, and 
sheep, and secondly in vivo in the rumen of dairy calves. Two of the 
vitamin D metabolites produced in the rumen fluid, metabolites Qj and Qg, 
were further isolated, purified, and partially characterized. Further 
research is required to identify Qj- and Q2. While and Q2 do not have 
bone mineral calcium mobilizing activity, they do have conflicting effects 
on vitamin D's bone mineral mobilizing activity, depending on the amount 
of Qj and Q2 used in relationship to the amount of vitamin D. Addi­
tional research is needed to determine the effect of and Q2 on intes­
tinal calcium absorption. Finally, was isolated circulating in the 
plasma of dairy calves fed [^H]-vitamin D. 
As discussed in the literature review section, vitamin D2 and vitamin 
Dg do not seem to be metabolized in an identical fashion in ruminants. 
This, in addition to results from Section 1 (i.e., vitamin D degradation 
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in the rumen), provided the foundation for research undertaken in Section 
2. Research described in Section 2 evaluated the metabolism of orally 
o 3 
administered [-^S]-vitamin and [ H]-vitamin D3 by dairy calves. These 
studies in Section 2 indicated that vitamin D2 and vitamin are not 
absorbed and metabolized identically in dairy calves. Twice the amount 
of [^H]-vitamin D3 and [^H]-vitamin D3 metabolites appears in the plasma 
when compared to [^H]-vitamin D2 and [^H]-vitamin D2 metabolites. In 
addition, [3H]-25-OH-D, [3H]-I,25-(0H)2-D, [%]-24,25-(0H)2-B, and [^H]-
25,26-(0H)2-D arising from [^H]-vitamin D^-treated calves were two- to 
fourfold less than the appearance of these metabolites in [^H]-vitamin 
Dg-treated calves. In summary, both studies (Section 1 and Section 2) 
indicate that vitamin D2 and vitamin D3 are degraded in the rumen, a 
metabolite produced from this vitamin D degradation in the rumen was iso­
lated circulating in the plasma, and finally a difference occurred in 
the absorption and metabolism of vitamin and vitamin Dg. 
As has been discussed already, these findings will be especially 
relevant to the animal industry. Vitamin D supplementation procedures 
for ruminants will require re-evaluation in view of the findings of this 
research. Finally, the difference in biological activity noted between 
vitamin and vitamin D3 must be considered when treating ruminants for 
vitamin D-related disorders. 
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